Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.55 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.55 |
| ▸ | GGH | Q92820 | 2/20 | 0.47 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.41 |
| ▸ | KDM4A | O75164 | 2/20 | 0.41 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.41 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.41 |
| ▸ | TET3 | O43151 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | GRM8 | O00222 | 1/20 | 0.40 |
| ▸ | GRM6 | O15303 | 1/20 | 0.40 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.40 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.40 |
| ▸ | GSR | P00390 | 1/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.40 |
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.40 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.40 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL2245116 | 1.00 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| Ammonia Solution, Strong SCHEMBL2150080 | 1.00 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| Ammonia Solution, Strong SCHEMBL3695091 | 0.98 | FOLH1 (0.57) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| Ammonia Solution, Strong SCHEMBL3695087 | 0.98 | FOLH1 (0.57) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| Ammonia Solution, Strong SCHEMBL3695083 | 0.98 | FOLH1 (0.57) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| SCHEMBL275407 | 0.96 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| SCHEMBL275405 | 0.96 | FOLH1 (0.55) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| SCHEMBL136061 | 0.96 | FOLH1 (0.59) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| SCHEMBL136060 | 0.96 | FOLH1 (0.59) | FOLH1NAALAD2RIMKLAGGHTET2 | |
| SCHEMBL1653628 | 0.94 | FOLH1 (0.57) | FOLH1NAALAD2RIMKLAGGHTET2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3508200-B1 | AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE | SBI PHARMACEUTICALS CO LTD (JP) | 2024-04-10 | — | — | EP | claimed |
| EP-3168296-B1 | AGENT FOR IMPROVING NORMAL DEVELOPMENT RATE OF FERTILIZED EGGS | SBI PHARMACEUTICALS CO LTD (JP) | 2020-09-09 | — | — | EP | claimed |
| CN-104487066-B | Prophylactic and/or therapeutic agent for radiation damage | 国立大学法人东京大学 | 2020-06-09 | — | — | CN | claimed |
| US-10675242-B2 | Aqueous formulation containing 5-aminolevulinic acid or the like | SBI PHARMACEUTICALS, CO., LTD. (JP) | 2020-06-09 | — | — | US | claimed |
| EP-2767278-B1 | ENHANCER OF SURVIVAL OF TRANSPLANTED ORGAN | SBI PHARMACEUTICALS CO LTD (JP) | 2019-11-06 | — | — | EP | claimed |
| EP-2875812-B1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR RADIATION DAMAGE | UNIV TOKYO (JP) | 2019-09-04 | — | — | EP | claimed |
| EP-3508200-A1 | AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE | SBI Pharmaceuticals Co., Ltd. (JP) | 2019-07-10 | — | — | EP | claimed |
| US-20190201336-A1 | AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE | SBI PHARMACEUTICALS, CO., LTD. (JP) | 2019-07-04 | — | — | US | claimed |
| EP-3281642-B1 | DIAGNOSTIC AGENT FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASES | SBI PHARMACEUTICALS CO LTD (JP) | 2019-05-01 | — | — | EP | claimed |
| EP-1878421-B1 | EXTERNAL PREPARATION FOR SKIN | SBI PHARMACEUTICALS CO LTD (JP) | 2019-04-03 | — | — | EP | claimed |
| EP-1743621-B1 | HAIR RESTORER | COSMO OIL CO LTD (JP) | 2014-03-05 | — | — | EP | claimed |
| US-8563605-B2 | Therapeutic agent for male sterility | SBI PHARMACEUTICALS CO., LTD. (JP) | 2013-10-22 | — | — | US | claimed |
| US-20130011337-A1 | THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASES | SBI PHARMACEUTICALS CO., LTD. (JP) | 2013-01-10 | — | — | US | claimed |
| US-20120122974-A1 | HAIR RESTORER | COSMO OIL CO., LTD. (JP) | 2012-05-17 | — | — | US | claimed |
| EP-2305237-A1 | THERAPEUTIC AGENT FOR MALE STERILITY | SBI ALApromo Co., Ltd. (JP) | 2011-04-06 | — | — | EP | claimed |
| US-20110065787-A1 | THERAPEUTIC AGENT FOR MALE STERILITY | SBI ALApromo., Ltd. | 2011-03-17 | — | — | US | claimed |
| US-20110060042-A1 | EXTERNAL PREPARATION FOR SKIN | SBI ALAPROMO CO., LTD. (JP) | 2011-03-10 | — | — | US | claimed |
| US-20100120916-A1 | THERAPEUTIC AGENT AND DIAGNOSTIC AGENT FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASES | SBI ALAPROMO CO., LTD. (JP) | 2010-05-13 | — | — | US | claimed |
| EP-2135613-A1 | REMEDY AND DIAGNOSTIC FOR MITOCHONDRIAL DYSFUNCTION BRAIN DISEASE | SBI ALApromo CO., LTD. (JP) | 2009-12-23 | — | — | EP | claimed |
| US-20090130227-A1 | EXTERNAL PREPARATION FOR SKIN | SBI ALAPROMO CO., LTD. (JP) | 2009-05-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10675242-B2 | Aqueous formulation containing 5-aminolevulinic acid or the like | ALAD, AAAS, SLC7A5 | FOLH1 148/4885NAALAD2 1872/4885RIMKLA 209/4885 |
| US-20190201336-A1 | AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE | ALAD, AAAS, SLC7A5 | FOLH1 135/4885NAALAD2 2378/4885RIMKLA 238/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.